vs
NETSCOUT SYSTEMS INC（NTCT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
NETSCOUT SYSTEMS INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$250.7M vs $207.3M），NETSCOUT SYSTEMS INC净利率更高（22.0% vs -62.0%，领先84.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -0.5%），NETSCOUT SYSTEMS INC自由现金流更多（$59.3M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 11.0%）
NETSCOUT SYSTEMS INC是美国科技企业，1984年由阿尼尔·辛哈尔与纳伦德拉·波帕特创立，前身为Frontier Software，总部位于马萨诸塞州韦斯特福德。公司专注于软件可观测性、深度数据包检测、DDoS防护及AIOps领域，为客户提供相关技术解决方案。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
NTCT vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $250.7M | $207.3M |
| 净利润 | $55.1M | $-128.6M |
| 毛利率 | 81.6% | — |
| 营业利润率 | 25.7% | -54.7% |
| 净利率 | 22.0% | -62.0% |
| 营收同比 | -0.5% | 25.9% |
| 净利润同比 | 13.0% | 3.5% |
| 每股收益（稀释后） | $0.75 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $250.7M | $207.3M | ||
| Q3 25 | $219.0M | $159.9M | ||
| Q2 25 | $186.7M | $166.5M | ||
| Q1 25 | $205.0M | $139.3M | ||
| Q4 24 | $252.0M | $164.6M | ||
| Q3 24 | $191.1M | $139.5M | ||
| Q2 24 | $174.6M | $147.0M | ||
| Q1 24 | $203.4M | $108.8M |
| Q4 25 | $55.1M | $-128.6M | ||
| Q3 25 | $25.8M | $-180.4M | ||
| Q2 25 | $-3.7M | $-115.0M | ||
| Q1 25 | $18.6M | $-151.1M | ||
| Q4 24 | $48.8M | $-133.2M | ||
| Q3 24 | $9.0M | $-133.5M | ||
| Q2 24 | $-443.4M | $-131.6M | ||
| Q1 24 | $-32.4M | $-170.7M |
| Q4 25 | 81.6% | — | ||
| Q3 25 | 80.1% | — | ||
| Q2 25 | 76.7% | — | ||
| Q1 25 | 77.7% | — | ||
| Q4 24 | 81.5% | — | ||
| Q3 24 | 78.0% | — | ||
| Q2 24 | 74.6% | — | ||
| Q1 24 | 75.3% | — |
| Q4 25 | 25.7% | -54.7% | ||
| Q3 25 | 14.8% | -106.9% | ||
| Q2 25 | -3.5% | -64.8% | ||
| Q1 25 | 9.7% | -102.6% | ||
| Q4 24 | 24.5% | -74.3% | ||
| Q3 24 | 7.4% | -94.6% | ||
| Q2 24 | -265.4% | -79.1% | ||
| Q1 24 | -18.2% | -151.9% |
| Q4 25 | 22.0% | -62.0% | ||
| Q3 25 | 11.8% | -112.8% | ||
| Q2 25 | -2.0% | -69.0% | ||
| Q1 25 | 9.1% | -108.5% | ||
| Q4 24 | 19.4% | -80.9% | ||
| Q3 24 | 4.7% | -95.7% | ||
| Q2 24 | -254.0% | -89.5% | ||
| Q1 24 | -15.9% | -156.8% |
| Q4 25 | $0.75 | $-1.28 | ||
| Q3 25 | $0.35 | $-1.81 | ||
| Q2 25 | $-0.05 | $-1.17 | ||
| Q1 25 | $0.28 | $-1.57 | ||
| Q4 24 | $0.67 | $-1.34 | ||
| Q3 24 | $0.13 | $-1.40 | ||
| Q2 24 | $-6.20 | $-1.52 | ||
| Q1 24 | $-0.43 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $540.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.6B | $-80.0M |
| 总资产 | $2.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $540.6M | $421.0M | ||
| Q3 25 | $483.4M | $202.5M | ||
| Q2 25 | $489.6M | $176.3M | ||
| Q1 25 | $457.4M | $127.1M | ||
| Q4 24 | $398.4M | $174.0M | ||
| Q3 24 | $363.4M | $150.6M | ||
| Q2 24 | $362.2M | $480.7M | ||
| Q1 24 | $389.7M | $112.3M |
| Q4 25 | $1.6B | $-80.0M | ||
| Q3 25 | $1.6B | $9.2M | ||
| Q2 25 | $1.5B | $151.3M | ||
| Q1 25 | $1.6B | $144.2M | ||
| Q4 24 | $1.5B | $255.0M | ||
| Q3 24 | $1.5B | $346.8M | ||
| Q2 24 | $1.4B | $432.4M | ||
| Q1 24 | $1.9B | $140.3M |
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.2B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.1B | $1.6B | ||
| Q1 24 | $2.6B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $62.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $59.3M | $-100.8M |
| 自由现金流率自由现金流/营收 | 23.6% | -48.6% |
| 资本支出强度资本支出/营收 | 1.1% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.13× | — |
| 过去12个月自由现金流最近4个季度 | $275.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $62.1M | $-99.8M | ||
| Q3 25 | $6.7M | $-91.4M | ||
| Q2 25 | $73.6M | $-108.3M | ||
| Q1 25 | $141.5M | $-166.5M | ||
| Q4 24 | $41.5M | $-79.3M | ||
| Q3 24 | $-3.7M | $-67.0M | ||
| Q2 24 | $38.4M | $-77.0M | ||
| Q1 24 | $93.6M | $-190.7M |
| Q4 25 | $59.3M | $-100.8M | ||
| Q3 25 | $4.4M | $-92.7M | ||
| Q2 25 | $71.7M | $-110.7M | ||
| Q1 25 | $140.1M | $-167.8M | ||
| Q4 24 | $39.6M | $-79.5M | ||
| Q3 24 | $-4.6M | $-68.6M | ||
| Q2 24 | $37.2M | $-79.0M | ||
| Q1 24 | $92.0M | $-193.9M |
| Q4 25 | 23.6% | -48.6% | ||
| Q3 25 | 2.0% | -58.0% | ||
| Q2 25 | 38.4% | -66.5% | ||
| Q1 25 | 68.4% | -120.5% | ||
| Q4 24 | 15.7% | -48.3% | ||
| Q3 24 | -2.4% | -49.2% | ||
| Q2 24 | 21.3% | -53.7% | ||
| Q1 24 | 45.2% | -178.2% |
| Q4 25 | 1.1% | 0.5% | ||
| Q3 25 | 1.0% | 0.8% | ||
| Q2 25 | 1.0% | 1.5% | ||
| Q1 25 | 0.7% | 1.0% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.7% | 1.4% | ||
| Q1 24 | 0.8% | 3.0% |
| Q4 25 | 1.13× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 7.60× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | -0.41× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTCT
| Services | $129.0M | 51% |
| Products | $121.7M | 49% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
